Pain Inflammation | J. P. Hemp Company

Pain & Inflammation — J.P. Hemp Company

Botanical illustration — white willow branch with leaves and bark, representing the pain and inflammation research pillar — Pain & Inflammation — Cannabinoid Research Pillar

Pain is not a single biological phenomenon — different types involve different mechanisms, and cannabinoid research has examined each type differently. This pillar covers the research landscape from the mechanisms of inflammatory signaling to the human trial evidence for CBD in specific pain conditions.

Start Here — Your Experience

Living with Chronic Pain For the person whose pain has become the background of daily life — what the research on CBG, CBD, and pain has examined. Experience · Plain language

Joint Pain and Inflammation — What the Research Shows For the person with arthritis or persistent joint pain — what CB2 receptors in synovial tissue are and what CBG's anti-inflammatory research has found. Experience · Plain language

Living with Fibromyalgia — What the Research Shows For the person with fibromyalgia searching for honest cannabinoid information — what the research has found about the ECS, central sensitisation, and the honest limits. Experience · Plain language

Exercise Recovery and Cannabinoids: What the Research Shows For the person whose body takes longer to recover from training, physical work, or exertion — what the ECS, inflammation, and cortisol dynamics of physical stress show about recovery. Experience · Plain language

Cannabinoids and Pain: An Overview Pain is not a single thing — different types involve different biological mechanisms, and cannabinoid research has examined each type differently. Pillar anchor · Start here

CBG and Inflammatory Signaling How CBG interacts with the body's inflammation pathways — what preclinical research has found about this cannabinoid's anti-inflammatory properties. Tier 2 · Preclinical

CBG and Pain: Preclinical Evidence CBG outperformed THC in some nociception models — what that finding actually means, how its three pain-relevant mechanisms work together, and where the human trial gap stands. Tier 2 · Preclinical

CBD and Pain Research: Evidence and Limits What controlled research has actually examined about CBD and pain — the specific pain types studied, what was found, and where the evidence runs out. Tier 1 · Human trials

Neuroinflammation and Cannabinoids Inflammation inside the brain and spinal cord — what it is, why it matters in neurological disease, and what research has found about cannabinoids and this process. Tier 2 · Preclinical

CBG and Joint Health: Anti-Inflammatory Preclinical Research CB2 receptors in synovial tissue and CBG's documented anti-inflammatory mechanisms — what the preclinical evidence shows and how it differs from pharmaceutical CBG derivatives. Tier 2 · Preclinical

CBD and Topical Joint Applications: What the Evidence Shows Synovial tissue expresses CB2 receptors and transdermal CBD has reached joint tissue in animal models — what the evidence shows and what remains to be established. Tier 2 · Preclinical & early human

Chronic Pain, Central Sensitisation, and the ECS Central sensitisation transforms acute pain into an amplified, persistent state — what research shows about the ECS in this transition and what it means for cannabinoid research. Tier 2 · Preclinical